학술논문
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
Document Type
Review Article
Source
In Lung Cancer August 2022 170:41-51
Subject
Language
ISSN
0169-5002